Is The Pharmaceutical Industry Shaping Up To Be The New IT?
US Drug Shortages and India’s Competitive Advantage
Given the shared traits between the pharmaceutical and IT industries, it’s worth pondering whether the pharmaceutical industry is on its way to becoming the new IT. Mandar Wagh delves into the dynamics of the US drug shortage, India’s competitive edge and the technological revolution within the industry, all of which are setting the stage for unparalleled growth
Over the past few months, the Indian benchmark indices have witnessed a significant rally, breaking away from their previously observed range-bound fluctuations. This momentum has propelled the indices to attain unprecedented highs, consequently leading to gains of around 10-11 per cent for both the BSE Sensex and Nifty 50 over the past six months. The robust performance can be attributed to an overarching positive sentiment that goes beyond the broader market and encompasses specific industries as well. Notably, Nifty Pharma, an index tracking the pharmaceutical industry, has demonstrated exceptional resilience.
To read the entire article, you must be a DSIJ magazine subscriber.
Current print subscribers click here to login
Subscribe now to get DSIJ All Access